A PHASE-II TRIAL OF 2,5-DIAZIRIDINYL3,6-BIS(CARBOETHOXYAMINO)1,4-BENZOQUINONE(AZQ,NSC-182986) IN RECURRENT PRIMARY BRAIN-TUMORS

被引：25

作者：

FEUN, LG

YUNG, WKA

LEAVENS, ME

BURGESS, MA

OBBENS, EA

BEDIKIAN, AY

SAVARAJ, N

STEWART, DJ

BENJAMIN, RS

FIELDS, WS

BODEY, GP

机构：

[1] UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,DEPT INTERNAL MED,MELANOMA SARCOMA SECT,HOUSTON,TX 77030

[2] UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,DEPT DEV THERAPEUT,HOUSTON,TX 77030

[3] KING FAISAL SPECIALIST HOSP & RES SECT,DEPT MED AFFAIRS,MED ONCOL SECT,RIYADH,SAUDI ARABIA

来源：

JOURNAL OF NEURO-ONCOLOGY | 1984年 / 2卷 / 01期

关键词：

D O I：

10.1007/BF00165153

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：13 / 17

页数：5

共 18 条

[1]

ARONEY RS, 1982, ASCO, V1, P24

[2]

BEDIKIAN AY, 1981, CANCER CLIN TRIALS, V4, P459

[3] POTENTIAL CENTRAL NERVOUS-SYSTEM ANTITUMOR AGENTS - AZIRIDINYLBENZOQUINONES .2. [J].

CHOU, F ;

KHAN, AH ;

DRISCOLL, JS .

JOURNAL OF MEDICINAL CHEMISTRY, 1976, 19 (11) :1302-1308

[4]

CURT GA, 1982, ASCO, V1, P13

[5] POTENTIAL CNS ANTI-TUMOR AGENTS .6. AZIRIDINYLBENZOQUINONES-III [J].

DRISCOLL, JS ;

DUDECK, L ;

CONGLETON, G ;

GERAN, RI .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1979, 68 (02) :185-188

[6]

DRISCOLL JS, 1977, CHEM ABST, V87, P194

[7] PHASE-II STUDIES OF DIANHYDROGALACTITOL-BASED COMBINATION CHEMOTHERAPY FOR RECURRENT BRAIN-TUMORS [J].

EAGAN, RT ;

CREAGAN, ET ;

BISEL, HF ;

LAYTON, DD ;

GROOVER, RV ;

HERMAN, RC .

ONCOLOGY, 1981, 38 (01) :4-6

[8]

Feun L G, 1983, J Neurooncol, V1, P45

[9]

Feun L G, 1983, J Neurooncol, V1, P219, DOI 10.1007/BF00165606

[10]

GEHAN EA, 1965, BIOMETRIKA, V52, P203, DOI 10.1093/biomet/52.1-2.203

← 1 2 →